3,4-Dimethoxy-a-(1-methylethyl)benzeneacetonitrile
CAS: 20850-49-1
Rif. 3D-ID145567
1g | 194,00 € | ||
2g | 310,00 € | ||
5g | 436,00 € | ||
10g | 647,00 € | ||
25g | 1.160,00 € |
Informazioni sul prodotto
- Verapamil impurity K
- (±)-2-(3,4-Dimethoxyphenyl)-3-methylbutanenitrile
- (±)-3,4-Dimethoxy-α-isopropylbenzeneacetonitrile
- 2-(3,4-Dimethoxy phenyl)-d-methylbutyronitrile
- 2-(3,4-Dimethoxy phenyl)-β-methylbutyronitrile
- 2-(3,4-Dimethoxyphenyl)-2-isopropylacetonitrile
- 2-(3,4-Dimethoxyphenyl)-3-Methyl Butyronitrile
- 3,4-Dimethoxy-α-(1-methylethyl)benzeneacetonitrile
- 3-Methyl-2-(3,4-dimethoxyphenyl)butyronitrile
- Benzeneacetonitrile, 3,4-dimethoxy-α-(1-methylethyl)-
- Vedi altri sinonimi
- Butyronitrile, 2-(3,4-dimethoxyphenyl)-3-methyl-
- Isopropyl(3,4-dimethoxyphenyl)acetonitrile
- alpha-Isopropyl homoveratronitrile
- α-Isopropylhomoveratronitrile
- α-Isopropylveratryl cyanide
3,4-Dimethoxy-a-(1-methylethyl)benzeneacetonitrile (DXM) is a synthetic phenylethylamine that is usually found in cough suppressant preparations. It has been shown to be able to cross the blood-brain barrier, and it has a constant, steady-state concentration. DXM is metabolized by N-demethylation in the liver by cytochrome P450 enzymes. This metabolism can be inhibited with the use of drugs such as chlorpromazine or ketoconazole. Pharmacokinetic modeling has been used to analyze and predict the pharmacokinetics of DXM. The drug DXM can also be synthesized from phenylacetonitrile and hydrochloric acid.
Proprietà chimiche
Richiesta tecnica su: 3D-ID145567 3,4-Dimethoxy-a-(1-methylethyl)benzeneacetonitrile
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.